Simtomax® has obtained TGA registration, allowing for commercialization in Australia

4 May 2014

Augurix and HealthScreenSolutions Pty Ltd are pleased to announce that Simtomax®, a rapid point-of-care diagnostic test for celiac disease, has been registered by the Australian Therapeutics Goods Administration (TGA).

Augurix and HealthScreenSolutions had entered into a commercialization agreement for Simtomax®, providing HealthScreenSolutions with the exclusive right to distribute and supply Simtomax® in Australia and New Zealand.

Get the PressRelease


Back to the news page »